TCF7L2 Modulates Glucose Homeostasis by Regulating CREB- and FoxO1-Dependent Transcriptional Pathway in the Liver

Peripheral insulin resistance contributes to the development of type 2 diabetes. TCF7L2 has been tightly associated with this disease, although the exact mechanism was largely elusive. Here we propose a novel role of TCF7L2 in hepatic glucose metabolism in mammals. Expression of medium and short isoforms of TCF7L2 was greatly diminished in livers of diet-induced and genetic mouse models of insulin resistance, prompting us to delineate the functional role of these isoforms in hepatic glucose metabolism. Knockdown of hepatic TCF7L2 promoted increased blood glucose levels and glucose intolerance with increased gluconeogenic gene expression in wild-type mice, in accordance with the PCR array data showing that only the gluconeogenic pathway is specifically up-regulated upon depletion of hepatic TCF7L2. Conversely, overexpression of a nuclear isoform of TCF7L2 in high-fat diet-fed mice ameliorated hyperglycemia with improved glucose tolerance, suggesting a role of this factor in hepatic glucose metabolism. Indeed, we observed a binding of TCF7L2 to promoters of gluconeogenic genes; and expression of TCF7L2 inhibited adjacent promoter occupancies of CREB, CRTC2, and FoxO1, critical transcriptional modules in hepatic gluconeogenesis, to disrupt target gene transcription. Finally, haploinsufficiency of TCF7L2 in mice displayed higher glucose levels and impaired glucose tolerance, which were rescued by hepatic expression of a nuclear isoform of TCF7L2 at the physiological level. Collectively, these data suggest a crucial role of TCF7L2 in hepatic glucose metabolism; reduced hepatic expression of nuclear isoforms of this factor might be a critical instigator of hyperglycemia in type 2 diabetes.

[1]  A. Wynshaw-Boris,et al.  Characterization of the phosphoenolpyruvate carboxykinase (GTP) promoter-regulatory region. II. Identification of cAMP and glucocorticoid regulatory domains. , 1986, The Journal of biological chemistry.

[2]  R. DePinho,et al.  The Kinase LKB1 Mediates Glucose Homeostasis in Liver and Therapeutic Effects of Metformin , 2005, Science.

[3]  J. Yates,et al.  Cooperative interactions between CBP and TORC2 confer selectivity to CREB target gene expression , 2007, The EMBO journal.

[4]  P. Puigserver,et al.  correction: CREB regulates hepatic gluconeogenesis through the coactivator PGC-1 , 2001, Nature.

[5]  Peter Almgren,et al.  Mechanisms by which common variants in the TCF7L2 gene increase risk of type 2 diabetes. , 2007, The Journal of clinical investigation.

[6]  Laura J. Scott,et al.  Tissue-specific alternative splicing of TCF7L2 , 2009, Human molecular genetics.

[7]  Masatoshi Hagiwara,et al.  Phosphorylated CREB binds specifically to the nuclear protein CBP , 1993, Nature.

[8]  L. Groop,et al.  Unique splicing pattern of the TCF7L2 gene in human pancreatic islets , 2009, Diabetologia.

[9]  Marc Montminy,et al.  PGC-1 promotes insulin resistance in liver through PPAR-α-dependent induction of TRB-3 , 2004, Nature Medicine.

[10]  F. Wondisford,et al.  Metformin and Insulin Suppress Hepatic Gluconeogenesis through Phosphorylation of CREB Binding Protein , 2009, Cell.

[11]  G. Tuteja,et al.  CRTC2 (TORC2) contributes to the transcriptional response to fasting in the liver but is not required for the maintenance of glucose homeostasis. , 2009, Cell metabolism.

[12]  Guillaume Adelmant,et al.  Control of hepatic gluconeogenesis through the transcriptional coactivator PGC-1 , 2001, Nature.

[13]  J. Folch,et al.  A simple method for the isolation and purification of total lipides from animal tissues. , 1957, The Journal of biological chemistry.

[14]  Hans Clevers,et al.  XTcf-3 Transcription Factor Mediates β-Catenin-Induced Axis Formation in Xenopus Embryos , 1996, Cell.

[15]  M. Karin,et al.  Activation of cAMP and mitogen responsive genes relies on a common nuclear factor , 1994, Nature.

[16]  Michael R. Green,et al.  Nuclear protein CBP is a coactivator for the transcription factor CREB , 1994, Nature.

[17]  Y. Iwamoto,et al.  Replication study for the association of TCF7L2 with susceptibility to type 2 diabetes in a Japanese population , 2007, Diabetologia.

[18]  S. R. Kulkarni,et al.  Common variants in the TCF7L2 gene are strongly associated with type 2 diabetes mellitus in the Indian population , 2006, Diabetologia.

[19]  K. Kaestner,et al.  Postprandial hepatic lipid metabolism requires signaling through Akt2 independent of the transcription factors FoxA2, FoxO1, and SREBP1c. , 2011, Cell metabolism.

[20]  M. Montminy,et al.  Targeted disruption of the CREB coactivator Crtc2 increases insulin sensitivity , 2010, Proceedings of the National Academy of Sciences.

[21]  S. Wakil,et al.  Continuous fat oxidation in acetyl–CoA carboxylase 2 knockout mice increases total energy expenditure, reduces fat mass, and improves insulin sensitivity , 2007, Proceedings of the National Academy of Sciences.

[22]  J. Yates,et al.  Insulin modulates gluconeogenesis by inhibition of the coactivator TORC2. , 2007, Nature.

[23]  M. Nóbrega,et al.  Alterations in TCF7L2 expression define its role as a key regulator of glucose metabolism. , 2011, Genome research.

[24]  David M Nathan,et al.  TCF7L2 polymorphisms and progression to diabetes in the Diabetes Prevention Program. , 2006, The New England journal of medicine.

[25]  K. Kaestner,et al.  Insulin resistance and a diabetes mellitus-like syndrome in mice lacking the protein kinase Akt2 (PKB beta). , 2001, Science.

[26]  S. Das,et al.  Transcription factor 7-like 2 polymorphisms and type 2 diabetes, glucose homeostasis traits and gene expression in US participants of European and African descent , 2007, Diabetologia.

[27]  Michael Kühl,et al.  Functional interaction of β-catenin with the transcription factor LEF-1 , 1996, Nature.

[28]  Jerry Donovan,et al.  Insulin-regulated hepatic gluconeogenesis through FOXO1-PGC-1alpha interaction. , 2003, Nature.

[29]  H. Shin,et al.  Type 2 diabetes-associated genetic variants discovered in the recent genome-wide association studies are related to gestational diabetes mellitus in the Korean population , 2009, Diabetologia.

[30]  F. Collins,et al.  Alternative Splicing of TCF7L2 Gene in Omental and Subcutaneous Adipose Tissue and Risk of Type 2 Diabetes , 2009, PloS one.

[31]  M. Magnuson,et al.  Cytosolic phosphoenolpyruvate carboxykinase does not solely control the rate of hepatic gluconeogenesis in the intact mouse liver. , 2007, Cell metabolism.

[32]  C. Kahn,et al.  Insulin regulates liver metabolism in vivo in the absence of hepatic Akt and Foxo1 , 2012, Nature Medicine.

[33]  Marc Montminy,et al.  PGC-1 promotes insulin resistance in liver through PPAR-alpha-dependent induction of TRB-3. , 2004, Nature medicine.

[34]  R. Scharfmann,et al.  Transcription Factor TCF7L2 Genetic Study in the French Population , 2006, Diabetes.

[35]  R. Evans,et al.  Class IIa Histone Deacetylases Are Hormone-Activated Regulators of FOXO and Mammalian Glucose Homeostasis , 2011, Cell.

[36]  D. Granner,et al.  Cyclic AMP-dependent protein kinase regulates transcription of the phosphoenolpyruvate carboxykinase gene but not binding of nuclear factors to the cyclic AMP regulatory element , 1990, Molecular and cellular biology.

[37]  Bruce M. Spiegelman,et al.  Insulin-regulated hepatic gluconeogenesis through FOXO1–PGC-1α interaction , 2003, Nature.

[38]  M. Montminy,et al.  TORC2 regulates hepatic insulin signaling via a mammalian phosphatidic acid phosphatase, LIPIN1. , 2009, Cell metabolism.

[39]  Paul Polakis,et al.  Stabilization of β-Catenin by Genetic Defects in Melanoma Cell Lines , 1997, Science.

[40]  H. Clevers,et al.  Wnt signalling in stem cells and cancer , 2005, Nature.

[41]  C. Kahn,et al.  Divergent regulation of hepatic glucose and lipid metabolism by phosphoinositide 3-kinase via Akt and PKClambda/zeta. , 2006, Cell metabolism.

[42]  J. Gulcher,et al.  Refining the impact of TCF7L2 gene variants on type 2 diabetes and adaptive evolution , 2007, Nature Genetics.

[43]  P. Robbins,et al.  Stabilization of beta-catenin by genetic defects in melanoma cell lines. , 1997, Science.

[44]  T. Jin,et al.  TCF-4 mediates cell type-specific regulation of proglucagon gene expression by beta-catenin and glycogen synthase kinase-3beta. , 2005, The Journal of biological chemistry.

[45]  T. Jin,et al.  TCF-4 Mediates Cell Type-specific Regulation of Proglucagon Gene Expression by β-Catenin and Glycogen Synthase Kinase-3β* , 2005, Journal of Biological Chemistry.

[46]  K. Maedler,et al.  Transcription Factor 7-Like 2 Regulates β-Cell Survival and Function in Human Pancreatic Islets , 2008, Diabetes.

[47]  C. Kahn,et al.  Insulin signalling and the regulation of glucose and lipid metabolism , 2001, Nature.

[48]  P. Froguel,et al.  A genetic variation of the transcription factor 7-like 2 gene is associated with risk of type 2 diabetes in the Japanese population , 2007, Diabetologia.

[49]  H. Stefánsson,et al.  Variant of transcription factor 7-like 2 (TCF7L2) gene confers risk of type 2 diabetes , 2006, Nature Genetics.

[50]  M. McCarthy,et al.  TCF7L2: the biggest story in diabetes genetics since HLA? , 2006, Diabetologia.

[51]  R. DeFronzo,et al.  Chromatin occupancy of transcription factor 7-like 2 (TCF7L2) and its role in hepatic glucose metabolism , 2011, Diabetologia.

[52]  R Grosschedl,et al.  Functional interaction of beta-catenin with the transcription factor LEF-1. , 1996, Nature.

[53]  A. Hecht,et al.  Alternative splicing of Tcf7l2 transcripts generates protein variants with differential promoter-binding and transcriptional activation properties at Wnt/β-catenin targets , 2009, Nucleic acids research.

[54]  R. Walther,et al.  Identification of a cAMP response element within the glucose- 6-phosphatase hydrolytic subunit gene promoter which is involved in the transcriptional regulation by cAMP and glucocorticoids in H4IIE hepatoma cells. , 1999, The Biochemical journal.

[55]  K. Kaestner,et al.  Insulin Resistance and a Diabetes Mellitus-Like Syndrome in Mice Lacking the Protein Kinase Akt2 (PKBβ) , 2001 .

[56]  R. Duggirala,et al.  Haplotypes of Transcription Factor 7–Like 2 (TCF7L2) Gene and Its Upstream Region Are Associated With Type 2 Diabetes and Age of Onset in Mexican Americans , 2007, Diabetes.

[57]  H. Clevers.  Wnt/beta-catenin signaling in development and disease. , 2006, Cell.

[58]  C. Dina,et al.  TCF7L2 Variation Predicts Hyperglycemia Incidence in a French General Population , 2006, Diabetes.

[59]  Marc Montminy,et al.  CREB regulates hepatic gluconeogenesis through the coactivator PGC-1 , 2001, Nature.

[60]  K. Kinzler,et al.  A simplified system for generating recombinant adenoviruses. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[61]  F. Horber,et al.  Effects of TCF7L2 Polymorphisms on Obesity in European Populations , 2008, Obesity.

[62]  M. Montminy,et al.  The CREB coactivator TORC2 is a key regulator of fasting glucose metabolism , 2005, Nature.

[63]  B. Herrmann,et al.  Nuclear localization of β-catenin by interaction with transcription factor LEF-1 , 1996, Mechanisms of Development.